LymphedemaV1, Ncbi, Merge, bibRecord, 000220

Combined inguinal and pelvic lymph node dissection for stage III melanoma.

Identifieur interne : 000220 ( Ncbi/Merge ); précédent : 000219; suivant : 000221

Combined inguinal and pelvic lymph node dissection for stage III melanoma.

Auteurs : T M Hughes [Royaume-Uni] ; J M Thomas

Source :

The British journal of surgery [ 0007-1323 ] ; 1999.

RBID : pubmed:10594495

Descripteurs français

KwdFr :
- Analyse de survie, Canal inguinal, Facteurs de risque, Humains, Lymphadénectomie (), Mélanome (), Mélanome (secondaire), Métastase lymphatique, Pelvis, Tumeurs cutanées (), Tumeurs cutanées (anatomopathologie).
MESH :
- anatomopathologie : Tumeurs cutanées.
- secondaire : Mélanome.
- Analyse de survie, Canal inguinal, Facteurs de risque, Humains, Lymphadénectomie, Mélanome, Métastase lymphatique, Pelvis, Tumeurs cutanées.

English descriptors

KwdEn :
- Humans, Inguinal Canal, Lymph Node Excision (methods), Lymphatic Metastasis, Melanoma (secondary), Melanoma (surgery), Pelvis, Risk Factors, Skin Neoplasms (pathology), Skin Neoplasms (surgery), Survival Analysis.
MESH :
- methods : Lymph Node Excision.
- pathology : Skin Neoplasms.
- secondary : Melanoma.
- surgery : Melanoma, Skin Neoplasms.
- Humans, Inguinal Canal, Lymphatic Metastasis, Pelvis, Risk Factors, Survival Analysis.

Abstract

The incidence of melanoma is increasing in the UK and a significant number of patients are still presenting with primary lesions of poor prognosis. As a consequence there is likely to be an increasing number of patients with lymph node metastases for whom the appropriate extent of groin dissection remains controversial. This review summarizes the evidence to enable surgeons to make an informed decision about the management of patients with melanoma metastases to the groin lymph nodes.

DOI: 10.1046/j.1365-2168.1999.01316.x
PubMed: 10594495

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 004B70
to stream PubMed, to step Curation: 004B70
to stream PubMed, to step Checkpoint: 004B70

Links to Exploration step

pubmed:10594495

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Combined inguinal and pelvic lymph node dissection for stage III melanoma.</title>
<author><name sortKey="Hughes, T M" sort="Hughes, T M" uniqKey="Hughes T" first="T M" last="Hughes">T M Hughes</name>
<affiliation wicri:level="3"><nlm:affiliation>Melanoma and Sarcoma Unit, Royal Marsden Hospital NHS Trust, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Melanoma and Sarcoma Unit, Royal Marsden Hospital NHS Trust, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Thomas, J M" sort="Thomas, J M" uniqKey="Thomas J" first="J M" last="Thomas">J M Thomas</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1999">1999</date>
<idno type="RBID">pubmed:10594495</idno>
<idno type="pmid">10594495</idno>
<idno type="doi">10.1046/j.1365-2168.1999.01316.x</idno>
<idno type="wicri:Area/PubMed/Corpus">004B70</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004B70</idno>
<idno type="wicri:Area/PubMed/Curation">004B70</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004B70</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004B70</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004B70</idno>
<idno type="wicri:Area/Ncbi/Merge">000220</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Combined inguinal and pelvic lymph node dissection for stage III melanoma.</title>
<author><name sortKey="Hughes, T M" sort="Hughes, T M" uniqKey="Hughes T" first="T M" last="Hughes">T M Hughes</name>
<affiliation wicri:level="3"><nlm:affiliation>Melanoma and Sarcoma Unit, Royal Marsden Hospital NHS Trust, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Melanoma and Sarcoma Unit, Royal Marsden Hospital NHS Trust, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Thomas, J M" sort="Thomas, J M" uniqKey="Thomas J" first="J M" last="Thomas">J M Thomas</name>
</author>
</analytic>
<series><title level="j">The British journal of surgery</title>
<idno type="ISSN">0007-1323</idno>
<imprint><date when="1999" type="published">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term>
<term>Inguinal Canal</term>
<term>Lymph Node Excision (methods)</term>
<term>Lymphatic Metastasis</term>
<term>Melanoma (secondary)</term>
<term>Melanoma (surgery)</term>
<term>Pelvis</term>
<term>Risk Factors</term>
<term>Skin Neoplasms (pathology)</term>
<term>Skin Neoplasms (surgery)</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Analyse de survie</term>
<term>Canal inguinal</term>
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Lymphadénectomie ()</term>
<term>Mélanome ()</term>
<term>Mélanome (secondaire)</term>
<term>Métastase lymphatique</term>
<term>Pelvis</term>
<term>Tumeurs cutanées ()</term>
<term>Tumeurs cutanées (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs cutanées</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="secondaire" xml:lang="fr"><term>Mélanome</term>
</keywords>
<keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Melanoma</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Inguinal Canal</term>
<term>Lymphatic Metastasis</term>
<term>Pelvis</term>
<term>Risk Factors</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Analyse de survie</term>
<term>Canal inguinal</term>
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Mélanome</term>
<term>Métastase lymphatique</term>
<term>Pelvis</term>
<term>Tumeurs cutanées</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The incidence of melanoma is increasing in the UK and a significant number of patients are still presenting with primary lesions of poor prognosis. As a consequence there is likely to be an increasing number of patients with lymph node metastases for whom the appropriate extent of groin dissection remains controversial. This review summarizes the evidence to enable surgeons to make an informed decision about the management of patients with melanoma metastases to the groin lymph nodes.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10594495</PMID>
<DateCreated><Year>2000</Year>
<Month>01</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted><Year>2000</Year>
<Month>01</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0007-1323</ISSN>
<JournalIssue CitedMedium="Print"><Volume>86</Volume>
<Issue>12</Issue>
<PubDate><Year>1999</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>The British journal of surgery</Title>
<ISOAbbreviation>Br J Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Combined inguinal and pelvic lymph node dissection for stage III melanoma.</ArticleTitle>
<Pagination><MedlinePgn>1493-8</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The incidence of melanoma is increasing in the UK and a significant number of patients are still presenting with primary lesions of poor prognosis. As a consequence there is likely to be an increasing number of patients with lymph node metastases for whom the appropriate extent of groin dissection remains controversial. This review summarizes the evidence to enable surgeons to make an informed decision about the management of patients with melanoma metastases to the groin lymph nodes.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A Medline search was performed to identify all English language articles about melanoma containing the words lymphadenectomy, lymph nodes, inguinal or lymphoedema. Eighty-seven relevant articles were selected from 3904 abstracts retrieved; 34 were related directly to the aim of this review.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There are no randomized controlled trials comparing the outcome of combined inguinal and pelvic lymph node dissection (CLND) and superficial inguinal lymph node dissection (SLND). Excision of pelvic lymph node metastases is reported to yield a 5-year survival rate of 0-35 per cent. Recurrence within the pelvis occurs in 9-18 per cent of patients after SLND and in less than 5 per cent after CLND. Morbidity following either CLND or SLND is poorly reported. Major long-term lymphoedema limiting patient activity affects 6-20 per cent of patients after groin dissection. Cloquet's node was demonstrated in one study to be a useful predictor of pelvic lymph node involvement. Patients may be selected for pelvic node dissection on the basis of clinical findings, the results of pelvic computed tomography and the status of Cloquet's node.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The controversy surrounding the appropriate management of cytologically positive inguinal nodes in melanoma can be resolved only by a prospective randomized trial comparing CLND with SLND. Morbidity and local disease control must be measured as outcomes in addition to disease-free and overall survival.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hughes</LastName>
<ForeName>T M</ForeName>
<Initials>TM</Initials>
<AffiliationInfo><Affiliation>Melanoma and Sarcoma Unit, Royal Marsden Hospital NHS Trust, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Thomas</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Br J Surg</MedlineTA>
<NlmUniqueID>0372553</NlmUniqueID>
<ISSNLinking>0007-1323</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007264" MajorTopicYN="N">Inguinal Canal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName>
<QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010388" MajorTopicYN="N">Pelvis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>34</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year>
<Month>12</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1999</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1999</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">10594495</ArticleId>
<ArticleId IdType="pii">bjs1316</ArticleId>
<ArticleId IdType="doi">10.1046/j.1365-2168.1999.01316.x</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Thomas, J M" sort="Thomas, J M" uniqKey="Thomas J" first="J M" last="Thomas">J M Thomas</name>
</noCountry>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Hughes, T M" sort="Hughes, T M" uniqKey="Hughes T" first="T M" last="Hughes">T M Hughes</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000220 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000220 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:10594495
   |texte=   Combined inguinal and pelvic lymph node dissection for stage III melanoma.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:10594495" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Combined inguinal and pelvic lymph node dissection for stage III melanoma.

Combined inguinal and pelvic lymph node dissection for stage III melanoma.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki